"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue
- PMID: 305823
Item in Clipboard
"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue
Cancer Treat Rep.
1978 Feb.
No abstract available
Similar articles
-
Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.Cancer Chemother Rep. 1974 Mar-Apr;58(2):275-80. Cancer Chemother Rep. 1974. PMID: 4598245 Clinical Trial. No abstract available.
-
High-dose methotrexate in osteogenic sarcoma: a 5-year experience.Cancer Treat Rep. 1978 Feb;62(2):259-64. Cancer Treat Rep. 1978. PMID: 346215 Clinical Trial. No abstract available.
-
Adjuvant chemotherapy for osteogenic sarcoma.Cancer Treat Rep. 1978 Feb;62(2):283-7. Cancer Treat Rep. 1978. PMID: 346218 Clinical Trial.
-
[Methotrexate-leucovorin rescue therapy: pharmacological characteristics and clinical effective use].Gan To Kagaku Ryoho. 1996 Dec;23(14):1901-6. Gan To Kagaku Ryoho. 1996. PMID: 8978794 Review. Japanese.
-
High-dose methotrexate with folinic acid rescue.Am J Hosp Pharm. 1977 Sep;34(9):961-5. Am J Hosp Pharm. 1977. PMID: 333910 Review.
Cited by
-
Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.Cancer Chemother Pharmacol. 1979;3(3):161-6. doi: 10.1007/BF00262416. Cancer Chemother Pharmacol. 1979. PMID: 316744 No abstract available.